Co-Authors
This is a "connection" page, showing publications co-authored by Giuseppe Curigliano and Javier Cortes.
Connection Strength
0.555
-
Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019. Eur J Cancer. 2020 08; 135:62-65.
Score: 0.221
-
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer. ESMO Open. 2020 05; 5(Suppl 3).
Score: 0.220
-
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology. JCO Glob Oncol. 2021 02; 7:162-172.
Score: 0.058
-
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy. Br J Cancer. 2020 09; 123(5):694-697.
Score: 0.056